Analysts expect over 2020 decreasing revenue Biogen

Tomorrow Biogen will publish its past quarters results. Over the current book year the total revenue from the company in Cambridge will be 13.39 billion USD (consensus estimates). This is slightly lower than 2019's revenue of 14.38 billion USD.

Historical revenues and results Biogen plus estimates 2020

The analysts expect for 2020 a net profit of 5.43 billion USD. For this year most of the analysts expect a profit per share of 33.43 USD. The price-earnings-ratio equals 8.13.

For this year analysts don't expect the company to pay a dividend. The average dividend yield of the biotech companies is a limited 0.11 percent.

Biogen 's market capitalization is based on the number of outstanding shares around 53.57 billion USD. The Biogen stock was the past 12 months quite volatile. Since last January the stock is 4 percent lower. This year the stock price moved between 223 and 375 dollar.

Historical stock prices Biogen

Click here for dividend Biogen. On Tuesday the stock closed at 271.67 USD.

Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.